CLINICAL EXPERIENCE WITH DKB
スポンサーリンク
概要
- 論文の詳細を見る
A new antibiotic, 3', 4'-dideoxykanamycin B (abbr. DKB) was administered to the intractable infections as the cases with basal disease as leukemia and anomalotrophy, or those with causative bacteria as <I>Pseudomonas</I>. The patients were children and newborns of pneumonia (including pyothorax), otitis media, pyelitis, meningitis and colitis. The results obtained were remarkably effective in 1 case, effective in 7 cases and ineffective in 3 cases. There experienced a case of pyothorax for which DKB was effective though the causative bacteria was kanamycin resistant <I>Pseudomonas aeruginosa</I>.
- 公益社団法人 日本化学療法学会の論文
公益社団法人 日本化学療法学会 | 論文
- DISPOSITION OF 7432-8 IN RATS (I)
- CLINICAL STUDIES ON T-1220 IN SURGICAL CASES
- CLINICAL STUDIES OF PIVALOYLOXYMETHYL D-α-AMINOBENZYL-PENICILLINATE HYDROCHLORIDE IN SURGICAL INFECTIONS
- STUDIES ON AC-1370
- Primary treatment with a combination of cyclophosphamide, vincristine, and dacarbazine for recurrent malignant pheochromocytoma: A case report.